Literature DB >> 19761614

Using vital statistics to estimate the population-level impact of osteoporotic fractures on mortality based on death certificates, with an application to France (2000-2004).

Nelly Ziadé1, Eric Jougla, Joël Coste.   

Abstract

BACKGROUND: We developed a methodology using vital statistics to estimate the impact of osteoporotic fractures on the mortality of an entire population, and applied it to France for the period 2000-2004.
METHODS: Current definitions of osteoporotic fractures were reviewed and their components identified. We used the International Classification of Diseases with national vital statistics data for the French adult population and performed cross-classifications between various components: age, sex, I-code (site) and E-code (mechanism of fracture). This methodology allowed identification of appropriate thresholds and categorization for each pertinent component.
RESULTS: 2,625,743 death certificates were analyzed, 2.2% of which carried a mention of fracture. Hip fractures represented 55% of all deaths from fracture. Both sexes showed a similar pattern of mortality rates for all fracture sites, the rate increased with age from the age of 70 years. The E-high-energy code (present in 12% of death certificates with fractures) was found to be useful to rule-out non-osteoporotic fractures, and to correct the overestimation of mortality rates. Using this methodology, the crude number of deaths associated with fractures was estimated to be 57,753 and the number associated with osteoporotic fractures 46,849 (1.85% and 1.78% of all deaths, respectively).
CONCLUSION: Osteoporotic fractures have a significant impact on overall population mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19761614      PMCID: PMC2758869          DOI: 10.1186/1471-2458-9-344

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  43 in total

1.  Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis.

Authors:  H K Genant; C Cooper; G Poor; I Reid; G Ehrlich; J Kanis; B E Nordin; E Barrett-Connor; D Black; J P Bonjour; B Dawson-Hughes; P D Delmas; J Dequeker; S Ragi Eis; C Gennari; O Johnell; C C Johnston; E M Lau; U A Liberman; R Lindsay; T J Martin; B Masri; C A Mautalen; P J Meunier; N Khaltaev
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

2.  The burden of osteoporotic fractures: a method for setting intervention thresholds.

Authors:  J A Kanis; A Oden; O Johnell; B Jonsson; C de Laet; A Dawson
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

3.  Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Authors:  J R Center; T V Nguyen; D Schneider; P N Sambrook; J A Eisman
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

4.  New guidelines for the prevention and treatment of osteoporosis. National Osteoporosis Foundation.

Authors:  J P Fulton
Journal:  Med Health R I       Date:  1999-03

Review 5.  Epidemiology and outcomes of osteoporotic fractures.

Authors:  Steven R Cummings; L Joseph Melton
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

Review 6.  Osteoporosis prevention, diagnosis, and therapy.

Authors: 
Journal:  JAMA       Date:  2001-02-14       Impact factor: 56.272

7.  Changes in hip fracture epidemiology: redistribution between ages, genders and fracture types.

Authors:  O Löfman; K Berglund; L Larsson; G Toss
Journal:  Osteoporos Int       Date:  2002-01       Impact factor: 4.507

8.  A rare clival and sellar fracture with pneumatocephalus.

Authors:  Frédéric Portier; Didier Salvan; Olivier Duruisseau; Philippe Herman; Patrice Tran Ba Huy
Journal:  Auris Nasus Larynx       Date:  2002-04       Impact factor: 1.863

9.  International variations in hip fracture probabilities: implications for risk assessment.

Authors:  John A Kanis; Olof Johnell; Chris De Laet; Bengt Jonsson; Anders Oden; Alan K Ogelsby
Journal:  J Bone Miner Res       Date:  2002-07       Impact factor: 6.741

10.  Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS).

Authors:  A A Ismail; S R Pye; W C Cockerill; M Lunt; A J Silman; J Reeve; D Banzer; L I Benevolenskaya; A Bhalla; J Bruges Armas; J B Cannata; C Cooper; P D Delmas; J Dequeker; G Dilsen; J A Falch; B Felsch; D Felsenberg; J D Finn; C Gennari; K Hoszowski; I Jajic; J Janott; O Johnell; J A Kanis; G Kragl; A Lopez Vaz; R Lorenc; G Lyritis; F Marchand; P Masaryk; C Matthis; T Miazgowski; M Naves-Diaz; H A P Pols; G Poor; A Rapado; H H Raspe; D M Reid; W Reisinger; C Scheidt-Nave; J Stepan; C Todd; K Weber; A D Woolf; T W O'Neill
Journal:  Osteoporos Int       Date:  2002-07       Impact factor: 4.507

View more
  5 in total

1.  Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study.

Authors:  Seo Young Kim; Sebastian Schneeweiss; Jun Liu; Daniel H Solomon
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

2.  Estimation of the lifetime risk of hip fracture for women and men in Canada.

Authors:  R B Hopkins; E Pullenayegum; R Goeree; J D Adachi; A Papaioannou; W D Leslie; J E Tarride; L Thabane
Journal:  Osteoporos Int       Date:  2011-05-11       Impact factor: 4.507

3.  Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis.

Authors:  Seo Young Kim; Sebastian Schneeweiss; Jun Liu; Gregory W Daniel; Chun-Lan Chang; Katie Garneau; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2010-08-03       Impact factor: 5.156

4.  Is Zolpidem Associated with Increased Risk of Fractures in the Elderly with Sleep Disorders? A Nationwide Case Cross-Over Study in Taiwan.

Authors:  Yih-Jing Tang; Shinn-Ying Ho; Fang-Ying Chu; Hung-An Chen; Yun-Ju Yin; Hua-Chin Lee; William Cheng-Chung Chu; Hui-Wen Yeh; Wei-Shan Chiang; Chia-Lun Yeh; Hui-Ling Huang; Nian-Sheng Tzeng
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

5.  Risk of Nonunion with Nonselective NSAIDs, COX-2 Inhibitors, and Opioids.

Authors:  Michael D George; Joshua F Baker; Charles E Leonard; Samir Mehta; Todd A Miano; Sean Hennessy
Journal:  J Bone Joint Surg Am       Date:  2020-07-15       Impact factor: 6.558

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.